WuXi AppTec

  • Senior Director to Executive Director, Global Process Development ( Cell/Gene Therapy)

    Job Locations CN-WuXi
    Job ID
    2019-5458
  • Overview

    In the short-to-medium term the priorities of these two senior directors or executive directors Global Process Development are to:

    • Report to VP, Global Process Engineering and help to build each Global Process Development team in China of 10 staff this year which could grow rapidly over time
    • Work with US colleagues on platforms already under development for AAV and Lenti
    • Further grow the China Process & Technology Development organization, in a manner that is well coordinated with the Process & Technology Development (US) organization, for future technologies

    Working location: Wuxi, China

    Responsibilities

    Key responsibilities:

     

    • Under the leader of VP of Global Process Engineering, co-development of global platforms, along with the US Product Development organization, with current focus on 3D platforms and viral vectors for the Advanced Therapies business: 
    • Partner with US Product Development, to develop platforms of cell lines and different manufacturing processes that are reproducible and scalable
    • Build out their organizations and organization skills so that their Global Product Development teams can work directly with global customers
    • Co-Develop platforms that can be licensed to customers for royalties and milestone payments
    • Participate in the development of global platforms and vector platforms that provide commercial scale production to customers, and more cost effective production for customers
    • Co-Develop platforms for cell or gene therapies, and produce cell lines where appropriate
    • Participate in the development of other key platforms in this area
    • Attend scientific conferences and represent WuXi to potential clients
    • Remain current on technologies to help maintain the organization’s long-term competitive position and profitability

    Qualifications

    Essential:

     

    • Ph.D. in pharmaceutical sciences, or a related field 
    • Experienced in viral and non-viral gene therapy product Process Development
    • Strong knowledge of cell culture techniques, gene therapy or cell therapy
    • Demonstrable evidence of building, developing and implementing Process Development systems in a systematic way
    • Experience of building and leading a group of senior scientists in Process Development
    • Technical Leader experience in multiple disciplines of science for Pharma and/or CRO business
    • Deep experience in bioreactors and cell line development 
    • Ability to build up quality yield from the upstream process
    • Fluent in English and Mandarin

      

    Preferred:

     

    • Second line management experience 
    • Expertise in the field of vectors and/or vaccines

     

    Key Attributes:

     

    • Able to work on multiple projects
    • Leadership  
    • Relationship building
    • Business acumen
    • Ability to influence in a matrixed environment

     

    THE COMPANY

     

    WuXi Advanced Therapies – Company Overview

     

    The Advanced Therapies business unit of WuXi AppTec is a global Contract Development and Manufacturing Organization (CDMO) dedicated to accelerating and transforming development, manufacturing, and commercialization of cell, gene, and other advanced biopharmaceuticals.

     

    Through continued internal reinvestment in facilities, technology, and talent combined with over three decades of biopharmaceutical testing expertise, WuXi Advanced Therapies have transformed their  services for cell and gene therapy companies into solutions that alleviate industry bottlenecks, accelerate time to market, and support commercial programs around the world.

     

    Serving clients that range from startup’s recently spun out of an academic institutions, to large pharma companies seeking to launch a product in new markets, WuXi Advanced Therapies integrated development, manufacturing, and testing services provide tailored services that are ideal for:

     

    • Viral and non-viralGene Therapies
    • Autologous and Allogeneic Cell Therapies
    • Gene Mediated and non-gene mediated Cell Therapies
    • Emerging technologies in cell gene therapy field like CRISPR/Cas9, NK cell, and Exosomes

     

    Their beginnings can be traced back to 1982 where, founded as ViroMed Laboratories (later AppTec) in the US, they offered clinical diagnostics with viral focus. Following the acquisition of AppTec by WuXi PharmaTech in 2008, the Philadelphia operations continued to manufacture cell banks and provide testing services for biopharmaceuticals, as WuXi AppTec. Integrated advanced therapies testing and manufacturing services were added in 2014, followed a year later by advanced therapies production (clinical & commercial scale) with the opening of 2 new facilities for cell therapy & gene therapy/viral vector manufacturing. In 2018 WuXi AppTec spun out advanced therapies manufacturing and testing operations in the US into a separate Business Unit; WuXi Advanced Therapies. Today, WuXi Advanced Therapies employ 600 staff across 4 facilities in the US and China. Turnover in 2019 is forecast to be in the region of US$150-200m

     

    For more information, please visit the official website: www.advancedtherapies.com

     

     

    WuXi AppTec

     

    WuXi AppTec Group is a leading global pharmaceutical, medical device open-access capability and technology platform company with global operations. As an innovation-driven and customer-focused company, WuXi AppTec Group provides a broad and integrated portfolio of services to help their worldwide customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions. With its industry-leading capabilities in small molecule R&D and manufacturing, cell therapy and gene therapy R&D and manufacturing, and medical device testing, WuXi platform is enabling more than 3,000 innovative collaborators from more than 30 countries to bring innovative healthcare products to patients, and to fulfil WuXi AppTec Group’s dream that “every drug can be made and every disease can be treated”.

     

    WuXi AppTec was developed from four founders and a single laboratory in 2001 to 26,000+ employees, 30+ R&D sites, manufacturing sites and offices worldwide, including 6+ million square feet of laboratory and manufacturing space, as well as facilities still under construction. The company is actively improving its capabilities and capacity through new expansions in its global business. Capitalizing on the advantage of conducting R&D services, WuXi AppTec is building an alternative R&D engine to serve the global life-science industry.

     

    For more information, please visit the official website: www.wuxiapptec.com.cn

     

     

    Equal Opportunity Employer Minorities/Women/Veterans/Disabled

     

    Join our Talent Community so we can keep you informed about upcoming events and opportunities that match your interests.

    https://careers-wuxiapptec.icims.com/connect

    Options

    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed

    Need help finding the right job?

    We can recommend jobs specifically for you! An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability Click here to get started.